Cargando…

Human Papillomavirus–Induced Cancer: Late Relapse in a Patient Treated With Tumor Necrosis Factor-Alpha Inhibitor

Detalles Bibliográficos
Autores principales:	Werberich, Gabriel Madeira, Strava, Tatiana, Vizioli, Carolina, Fernandes, Gustavo dos Santos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493224/ https://www.ncbi.nlm.nih.gov/pubmed/28717771 http://dx.doi.org/10.1200/JGO.2016.005835

Ejemplares similares

Computed tomography findings in a Brazilian cohort of 48 patients with pneumonia due to coronavirus disease
por: Werberich, Gabriel Madeira, et al.
Publicado: (2020)

Cystic airspaces associated with COVID-19 pneumonia
por: Rodrigues, Rosana Souza, et al.
Publicado: (2020)

Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab
por: Corrêa, Tatiana Strava, et al.
Publicado: (2018)

Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors – a single Brazilian center experience
por: Treistman, Natalia, et al.
Publicado: (2021)

Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment
por: Reitblat, Tatiana, et al.
Publicado: (2013)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

Late-Relapsing Hepatitis after Yellow Fever
por: Rezende, Izabela Maurício, et al.
Publicado: (2020)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Tumor Necrosis Factor Alpha Inhibitor-Induced Acute Pancreatitis
por: Werlang, Monia E., et al.
Publicado: (2017)

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
por: Takazono, Takahiro, et al.
Publicado: (2016)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Familial secondary hyperhidrosis associated with tumor necrosis factor–alpha inhibitor treatment
por: Ikediobi, Ogechi, et al.
Publicado: (2015)

The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis
por: Lee, Suhwan, et al.
Publicado: (2019)

Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
por: Zahedipour, Fatemeh, et al.
Publicado: (2022)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

Mechanisms of Tumor Necrosis Factor-Alpha Inhibitor-Induced Systemic Lupus Erythematosus
por: Yen, Chung-Yang, et al.
Publicado: (2022)

Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity
por: Olmos, Gabriel, et al.
Publicado: (2014)

Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy
por: Hirsch, Julianna, et al.
Publicado: (2016)

A stonemason with accelerated silicosis in the setting of tumour necrosis factor alpha inhibitor therapy
por: Baird, Timothy, et al.
Publicado: (2016)

Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors
por: Masukawa, Ena, et al.
Publicado: (2021)

The Utility of Frequent Laboratory Monitoring for Patients on Tumor Necrosis Factor-Alpha Inhibitors in Dermatology
por: Houpe, Jessica E., et al.
Publicado: (2022)

Evidence of recombination within human alpha-papillomavirus
por: Angulo, Manuel, et al.
Publicado: (2007)

Serum tumor necrosis factor alpha increased during remission with Etanercept
por: Spirchez, Mihaela, et al.
Publicado: (2011)

Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series
por: Czajkowska, Jadwiga B, et al.
Publicado: (2012)

Superior Orbital Fissure Syndrome and Ophthalmoplegia Caused by Varicella Zoster Virus with No Skin Eruption in a Patient Treated with Tumor Necrosis Alpha Inhibitor
por: Jensen, Helene, et al.
Publicado: (2015)

110. Improving Pneumococcal Vaccination in Patients Treated with Tumor Necrosis Factor-alpha Inhibitors: A Multidisciplinary Education-Based Quality Improvement Project
por: Curtin, John M, et al.
Publicado: (2022)

Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis
por: Özler, Kenan, et al.
Publicado: (2016)

Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017)

Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report
por: Pan, Xiaoli, et al.
Publicado: (2021)

Tumor Necrosis Factor-Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis: A Systematic Review
por: Nair, Shaalina, et al.
Publicado: (2022)

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
por: Kwak, Kihyuck, et al.
Publicado: (2014)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Late relapsing testicular cancer detected with 18F-FDG PET preceded by long-term alpha-fetoprotein elevation
por: Sakurai, Hiromichi, et al.
Publicado: (2023)

Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy
por: Stanulla, Martin, et al.
Publicado: (2001)

Late relapse of cutaneous larva migrans
por: Dam Larsen, Fredrikke, et al.
Publicado: (2023)

What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?
por: Leite, Ana Carolina Rathsam, et al.
Publicado: (2022)

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations
por: Accortt, Neil A, et al.
Publicado: (2017)

The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients
por: Yazısız, Veli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1dtp49d8dvkvg6lpsmthb2crs4